MedTrace Logo

Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound Examination

NCT03842631 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2019-02-19

No results posted yet for this study

Summary

The purpose of this study is to assess the safety and efficacy of Timolol Maleate treatment for different depth of infantile hemangioma based on B-ultrasonography. Based on the depth of hemangioma, patients will be proactively allocated to two groups. And then, all patients in both groups will receive topical timolol treatment in the same protocol and dosage.

Conditions

  • Infantile Hemangioma

Interventions

DRUG

Timolol Maleate 0.5% Oph Soln

External use of 0.5% Timolol Maleate Drops for all patients in different depths of IH lesion.

Sponsors & Collaborators

  • XiaoXi Lin

    lead OTHER

Principal Investigators

  • Xiaoxi Lin, PhD · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

Eligibility

Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-16
Primary Completion
2020-06-01
Completion
2020-12-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03842631 on ClinicalTrials.gov